Despite billion-dollar pandemic boost, AbCellera still seeks ‘escape velocity’ By Aleksandra Sagan and David Reevely
How AI gave Canada an early lead in finding new medicines—and how we could lose it By David Reevely and Aleksandra Sagan
Nowhere to grow: Canada’s biotech sector is booming, but a lack of lab space has some companies looking south By Catherine McIntyre
Alberta biotech group seeking $85M in federal funding to close ‘critical’ supply-chain gaps: Documents By Jesse Snyder
B.C.’s AbCellera pushing feds, province for ‘patent-box’ tax breaks for IP-heavy companies By Aleksandra Sagan
